The patented system utilizes CRISPR-Cas technology to selectively target and neutralize viral infections in human cells. This approach leverages the CRISPR-Cas13 system, a RNA-guided nuclease that specifically cleaves viral RNA,…
No topics were found here
Super Globals
Options and Features
Are you sure you want to delete this file?
File deleted successfully
Scroll to Top
Join Us
TeraOpenScience is an open collaboration platform bringing together students and professionals. Together, we transform innovative ideas into practical solutions and ready-to-launch business models.
